Hem › Leukemi › Wisconsin › Milwaukee
Kliniska studier för Leukemi i Milwaukee, WI
11 studier för Leukemi söker deltagare vid platser i och runt Milwaukee (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekryterarObservationsstudie
- Children's Hospital of Wisconsin, Milwaukee
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RekryterarFas 3
- Froedtert & Medical College of Wisconsin, Milwaukee
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekryterarFas 1
- Froedtert & Medical College Clinics, Milwaukee
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
RekryterarFas 1/2
- Research Site, Milwaukee
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RekryterarObservationsstudie
- Children's Hospital of Wisconsin, Milwaukee
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Rekryterar
- Children's Wisconsin, Milwaukee
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RekryterarFas 2/3
- Froedtert & Medical College of Wisconsin, Milwaukee
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
RekryterarFas 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekryterarFas 1
- Medical College of Wisconsin Cancer Center, Milwaukee
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Milwaukee
Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab
RekryterarObservationsstudie
- CIBMTR, Milwaukee
Leukemi-studier i andra städer
- Houston, TX28 studier
- Boston, MA25 studier
- New York City, NY19 studier
- Los Angeles, CA16 studier
- Chicago, IL16 studier
- Durham, NC13 studier
- Baldwin Park, CA12 studier
- Columbus, OH12 studier
- Nashville, TN12 studier
- Philadelphia, PA12 studier
- Atlanta, GA11 studier
- Seattle, WA11 studier
Andra studier i Milwaukee
- Bröstcancer23 studier
- Icke-småcellig lungcancer22 studier
- Cancer (alla typer)22 studier
- Lungcancer21 studier
- Multipelt myelom21 studier
- Prostatacancer20 studier
- Follikulärt lymfom19 studier
- Bukspottkörtelcancer18 studier
- Non-Hodgkins lymfom18 studier
- Äggstockscancer17 studier
- Akut myeloid leukemi17 studier
- Burkitts lymfom16 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.